Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification

Fig. 5

Box plots showing the T/N ratios of MET (a) and FLT (b) in relation to IDH1 mutation status in non-enhancing gliomas (n = 13). There was no significant difference in the median MET T/N ratios between IDH1-mutant (mut) and IDH1-wildtype (wt) tumours (a). The median FLT T/N ratio in IDH1-wildtype tumours was significantly higher than that in IDH1-mutant tumours (P = 0.028) (b)

Back to article page